0001179110-19-007732.txt : 20190614
0001179110-19-007732.hdr.sgml : 20190614
20190614180043
ACCESSION NUMBER: 0001179110-19-007732
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190612
FILED AS OF DATE: 20190614
DATE AS OF CHANGE: 20190614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lydon Nicholas
CENTRAL INDEX KEY: 0001639935
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37359
FILM NUMBER: 19900009
MAIL ADDRESS:
STREET 1: BLUEPRINT MEDICINES CORP.
STREET 2: 215 FIRST STREET, SUITE 340/350
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Blueprint Medicines Corp
CENTRAL INDEX KEY: 0001597264
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-374-7580
MAIL ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2019-06-12
0
0001597264
Blueprint Medicines Corp
BPMC
0001639935
Lydon Nicholas
C/O BLUEPRINT MEDICINES CORPORATION
45 SIDNEY STREET
CAMBRIDGE
MA
02139
1
0
0
0
Common Stock
2019-06-12
4
S
0
11200
85.75
D
166527
D
Common Stock
2019-06-12
4
S
0
6300
84.66
D
160227
D
Common Stock
2019-06-12
4
S
0
5200
83.83
D
155027
D
Common Stock
2019-06-12
4
S
0
2000
82.45
D
153027
D
Common Stock
2019-06-12
4
S
0
300
81.96
D
152727
D
Effected pursuant to a trading plan adopted on March 19, 2019 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.18 to $86.17 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (6) to this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.21 to $85.17 per share.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.18 to $84.16 per share.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.08 to $83.07 per share.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.90 to $82.07 per share.
/s/ Christopher Frankenfield, Attorney-in-Fact
2019-06-14